Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia

QR Code

Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia

Background & Aims: Fecal immunochemical tests (FITs) are used widely in colorectal cancer screening. Programs use the same fecal hemoglobin threshold for colonoscopy referral for men and women, but it is unclear whether FIT performs equally in both sexes. We therefore assessed FIT performance in...

Full description

Bibliographic Details
Main Authors:	Kapidzic, A., van der Meulen, M., Hol, L., van Roon, A., Looman, C., Lansdorp_Vogelaar, Iris, van Ballegooijen, M., van Vuuren, A., Reijerink, J., van Leerdam, M., Kuipers, E.
Format:	Journal Article
Published:	W.B. Saunders Co 2015
Online Access:	http://hdl.handle.net/20.500.11937/50000

Similar Items

Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)

A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study
by: Van Heijningen, E., et al.
Published: (2013)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)

Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands
by: Kroep, S., et al.
Published: (2014)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_30otm642sdh25u071cfijcdu3r